investorscraft@gmail.com

Intrinsic value of Integer Holdings Corporation (ITGR)

Previous Close$70.96
Intrinsic Value
Upside potential
Previous Close
$70.96
Use floor (the cash flow based valuation has rendered a result, which is lower than an estimated minimum value derived from the company’s balance sheet analysis)

VALUATION INPUT DATA (original, your and others' valuations)

ParameterOrig.Your
Date of valuation (DoV)  
Intrinsic value (IV) at DoV, $/sh  
IV at current val. algorithm, $/sh33.94 

The original valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-03-31.

Registered users can save their valuation input data

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.

Company description

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac and neuromodulation products, such as batteries, capacitors, filtered feedthroughs, and implantable leads; implanted medical devices, pacemakers, implantable cardioverter defibrillators, implantable cardiac pacing and defibrillation leads, and heart failure therapies, such as ventricular assist devices and cardiac resynchronization devices. In addition, the company offers rechargeable batteries and chargers, and non-rechargeable batteries; arthroscopic devices and components, including shaver blades and burrs, ablation probes, and suture anchors; and laparoscopic and general surgery products, such as harmonic scalpels, radio frequency probes, and ophthalmic surgery devices. Further, it provides orthopedic products, including hip and shoulder joint reconstruction implants, plates, screws, and spinal devices, as well as instruments and delivery systems used in hip and knee replacement, trauma fixation, extremity, and spine surgeries. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %13.9NaN
Revenue, $1222NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m1086NaN
Operating income, $m136NaN
EBITDA, $m225NaN
Interest expense (income), $mNaN
Earnings before tax, $m101NaN
Tax expense, $m8NaN
Net income, $m93NaN

BALANCE SHEET

Cash and short-term investments, $m18NaN
Total assets, $m2582NaN
Adjusted assets (=assets-cash), $m2564NaN
Average production assets, $m1998NaN
Working capital, $m293NaN
Total debt, $m898NaN
Total liabilities, $m1227NaN
Total equity, $m1355NaN
Debt-to-equity ratio0.663NaN
Adjusted equity ratio0.531NaN

CASH FLOW

Net income, $m93NaN
Depreciation, amort., depletion, $m90NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m157NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-53NaN
Free cash flow, $m210NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m293
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount